Page 867 - Williams Hematology ( PDFDrive )
P. 867

842            Part VI:  The Erythrocyte                                                                                                                  Chapter 54:  Hemolytic Anemia Resulting from Immune Injury               843




                 93.  Gralnick HR, Wright LD, McGinnis MH: Coombs’ positive reactions associated with     130. Arndt P, Garratty G: Cross-reactivity of cefotetan and ceftriaxone antibodies, associ-
                  sodium cephalothin therapy. JAMA 199:725, 1967.        ated with hemolytic anemia, with other cephalosporins and penicillin. Am J Clin Pathol
                 94.  Molthan L, Reidenberg MM, Eichman MF: Positive direct Coombs’ tests due to   118:256, 2002.
                  cephalothin. N Engl J Med 277:123, 1967.              131. Issitt PD, Pavone BG, Goldfinger D, et al: Anti-Wr  and other autoantibodies responsi-
                                                                                                     b
                 95.  Zeger G, Smith L, McQuiston D, Goldfinger D: Cisplatin-induced nonimmunologic   ble for positive direct antiglobulin test in 150 individuals. Br J Haematol 34:5, 1976.
                  adsorption of immunoglobulin by red cells. Transfusion 28:493, 1988.    132. Garratty G: Autoantibodies induced by blood transfusions. Transfusion 44:5, 2004.
                 96.  Muirhead EE, Groves M, Guy R, et al: Acquired hemolytic anemia, exposures to insecti-    133. Young PP, Uzieblo A, Trulock E, et al: Autoantibody formation after alloimmunization:
                  cides and positive Coombs’ test dependent on insecticide preparations. Vox Sang 4:277,   Are blood transfusions a risk factor for autoimmune hemolytic anemia? Transfusion
                  1959.                                                  44:67, 2004.
                 97.  Lindberg LG, Norden A: Severe hemolytic reaction to chlorpromazine. Acta Med Scand     134. Salama A, Mueller-Eckhardt C: Delayed hemolytic transfusion reactions: Evidence
                  170:195, 1961.                                         for complement activation involving allogeneic and autologous red cells. Transfusion
                 98.  Eyster ME: Melphalan (Alkeran) erythrocyte agglutinin and hemolytic anemia. Ann   24:188, 1984.
                  Intern Med 66:573, 1967.                              135. Ness PM, Shirey RS, Thoman SK, Buck SA: The differentiation of delayed serologic and
                 99.  Robinson MG, Foadi M: Hemolytic anemia with positive Coombs’ test. Association   delayed hemolytic transfusion reactions: Incidence, long-term serologic findings and
                  with isoniazid therapy. JAMA 208:656, 1969.            clinical significance. Transfusion 30:688, 1990.
                 100. Mueller-Eckhardt C, Kretschmer V, Coburg KH: Allergic, immunohemolytic anemia     136. Leddy JP, Falany JL, Kissel GE, et al: Erythrocyte membrane proteins reactive with
                  due to  para-aminosalicylic  acid  (PAS). Immunohematologic  studies  of  three cases.   human (warm-reacting) anti-red cell autoantibodies. J Clin Invest 91:1672, 1993.
                  Dtsch Med Wochenschr 97:234, 1972.                    137. Gorst DW, Rawlinson VI, Merry AH, Stratton F: Positive direct anti-globulin test in
                 101. Manor E, Marmor A, Kaufman S, Leiba H: Massive hemolysis caused by acetamino-  normal individuals. Vox Sang 38:99, 1980.
                  phen. JAMA 236:2777, 1976.                            138. Bareford D, Langster G, Gilks L, Demick-Torey LA: Follow-up of normal individuals
                 102. Vilal JM, Blum L, Dosik H: Thiazide-induced immune hemolytic anemia.  JAMA   with a positive antiglobulin test. Scand J Haematol 35:348, 1985.
                  236:1723, 1976.                                       139. Worlledge SM: The interpretation of a positive direct antiglobulin test. Br J Haematol
                 103. Letona JM-L, Barbolla L, Frieyro E, et al: Immune haemolytic anaemia and renal failure   39:157, 1978.
                  induced by streptomycin. Br J Haematol 35:561, 1977.    140. Nossal GJV: B-cell selection and tolerance. Curr Opin Immunol 3:193, 1991.
                 104. Korsager S, Sorensen H, Jensen OH, Falk JV: Antiglobulin tests for determination of     141. Basten A, Brink R, Peake P, et al: Self-tolerance in the B-cell repertoire. Immunol Rev
                  autoimmunohaemolytic anaemia during long-term treatment with ibuprofen. Scand J   122:5, 1991.
                  Rheumatol 10:174, 1981.                               142. Kroemer G, Martinez-A C: Mechanisms of self-tolerance. Immunol Today 13:401, 1992.
                 105. Takahashi H, Tsukada T: Triamterene-induced immune hemolytic anemia with acute     143. Leddy JP: Immune hemolytic anemia,  in Clinical Immunology: Principles and Practice,
                  intravascular hemolysis and acute renal failure. Scand J Haematol 23:169, 1979.  edited by RR Rich, TA Fleisher, BD Schwartz, WT Shearer, W Strober, p 1273. Mosby,
                 106. Wong KY, Boose GM, Issitt CH: Erythromycin-induced hemolytic anemia. J Pediatr   St. Louis, 1996.
                  98:647, 1981.                                         144. Hartley SB, Crosbie J, Brink R, et al: Elimination from peripheral lymphoid tissue of
                 107. Sandvei P, Nordhagen R, Michaelsen TE, Wolthuis K: Fluorouracil (5-FU) induced   self-reactive B lymphocytes recognizing membrane bound antigens. Nature 353:765,
                  acute immune haemolytic anaemia. Br J Haematol 65:357, 1987.  1991.
                 108. Tafani O, Mazzoli M, Landini G, Alterini B: Fatal acute immune haemolytic anaemia     145. Leddy JP: Reactivity of human gamma-G erythrocyte autoantibodies with fetal, autolo-
                  caused by nalidixic acid. Br Med J 285:936, 1982.      gous and maternal red cells. Vox Sang 17:525, 1969.
                 109. Angeles ML, Reid ME, Yacob UA, et al: Sulindac-induced immune hemolytic anemia.     146. Okamoto M, Murakami M, Shimizu A, et al: A transgenic model of autoimmune hemo-
                  Transfusion 34:255, 1994.                              lytic anemia. J Exp Med 175:71, 1992.
                 110. Marks DR, Joy JV, Bonheim NA: Hemolytic anemia associated with the use of omepra-    147. Murakami M, Tsubata T, Okamoto M, et al: Antigen-induced apoptotic death of Ly-1 B
                  zole. Am J Gastroenterol 86:217, 1991.                 cells responsible for autoimmune disease in transgenic mice. Nature 357:77, 1992.
                 111. Blum MD, Graham DJ, McCloskey CA: Temafloxacin syndrome: Review of 95 cases.     148. Lin RH, Mamula MJ, Hardin JA, Janeway CA: Induction of autoreactive B cells allows
                  Clin Infect Dis 18:946, 1994.                          priming of autoreactive T cells. J Exp Med 173:1433, 1991.
                 112. Marani TM, Trich MB, Armstrong KS, et al: Carboplatin-induced immune hemolytic     149. Silverman GJ, Carson DA: Structural characterization of human monoclonal cold
                  anemia. Transfusion 36:1016, 1996.                     agglutinins: Evidence for a distinct primary sequence-defined V 4 idiotype.  Eur J
                                                                                                              H
                 113. Freercks RJ, Mehta U, Stead DF, Meintjes GA: Haemolytic anaemia associated with efa-  Immunol 20:351, 1990.
                  virenz. AIDS 20:1212, 2006.                           150. Silberstein LE, Jefferies LC, Goldman J, et al: Variable region gene analysis of pathologic
                 114. Mayer B, Genth R, Dehner R, Salama A: The first example of a patient with etoricoxib-   human autoantibodies to the related i and I red blood cell antigens. Blood 78:2372,
                  induced immune hemolytic anemia. Transfusion 53:1033, 2013.  1991.
                 115. Sheik-Taha M, Frenn P: Autoimmune hemolytic anemia induced by levofloxacin. Case     151. Pascual V, Victor K, Spellerberg M, et al: V  restriction among human cold agglutinins:
                                                                                                H
                  Reports in Infectious Diseases, 2014. http://dx.doi.org/10.1155/2014/201015  The V 4–21 gene segment is required to encode anti-I and anti-i specificities. J Immu-
                                                                            H
                 116. Chen F, Liu S, Wu J: Puerarin-induced immune hemolytic anemia. Int J Hematol 98:112,   nol 149:2337, 1992.
                  2013                                                  152. Stevenson FK, Smith GJ, North J, et al: Identification of normal B-cell counterparts of
                 117. Gurbuz F, Yagci-Kupeli B, Kor Y, et al: The first report of cabergoline-induced immune   neoplastic cells which secrete cold agglutinins of anti-I and anti-i specificity. Br J Hae-
                  hemolytic anemia in an adolescent with prolactinoma. J Pediatr Endocrinol Metab 27:   matol 72:9, 1989.
                  159, 2013.                                            153. Silverman GJ, Chen PP, Carson DA: Cold agglutinins: Specificity, idiotype and struc-
                 118. Chaplin H, Avioli LV: Autoimmune hemolytic anemia.  Arch Intern Med 137:346,     tural analysis,  in Idiotypes in Biology and Medicine: Chemistry and Immunology, vol 48,
                  1977.                                                  edited by DA Carson, PP Chen, TJ Kipps, p 109. Karger, Basel, 1990.
                 119. Sallah S, Wan J, Hanrahan L: Future development of lymphoproliferative disorders in     154. Feizi T: Lambda chains in cold agglutinins. Science 156:111, 1987.
                  patients with autoimmune hemolytic anemia. Clin Cancer Res 7:791, 2001.    155. Thompson KM, Sutherland J, Barden G, et al: Human monoclonal antibodies against
                 120. Pirofsky B: Hereditary aspects of autoimmune hemolytic anemia: A retrospective anal-  blood group antigens preferentially express a V 4–21 variable region gene-associated
                                                                                                    H
                  ysis. Vox Sang 14:334, 1968.                           epitope. Scand J Immunol 34:509, 1991.
                 121. Dobbs CE: Familial auto-immune hemolytic anemia. Arch Intern Med 116:273, 1965.    156. Adderson EE, Shackelford PG, Quinn A, et al: Restricted immunoglobulin VH usage
                 122. Cordova MS, Baez-Villasenor J, Mendez JJ, Campos E: Acquired hemolytic anemia   and VDJ combinations in the human response to Haemophilus influenzae type b capsu-
                  with positive antiglobulin (Coombs’ test) in mother and daughter. Arch Intern Med   lar polysaccharide: Nucleotide sequences of monospecific anti-Haemophilus antibod-
                  117:692, 1966.                                         ies and polyspecific antibodies cross-reacting with self-antigens. J Clin Invest 91:2734,
                 123. Eyster ME, Jenkins DE Jr: Erythrocyte coating substances in patients with positive   1993.
                  direct antiglobulin reactions: Correlation of gamma-G globulin and complement     157. Adderson EE, Shackelford PG, Insel RA, et al: Immunoglobulin light chain variable
                  coating with underlying diseases, overt hemolysis and response to therapy. Am J Med   region gene sequences for human antibodies to Haemophilus influenzae type b capsular
                  46:360, 1969.                                          polysaccharide are dominated by a limited number of V kappa and V lambda segments
                 124. Feizi T: Cold agglutinins, the direct Coombs’ test and serum immunoglobulins in   and VJ combinations. J Clin Invest 89:729, 1992.
                  Mycoplasma pneumoniae infection. Ann N Y Acad Sci 143:801, 1967.    158. Silberstein LE, Robertson GA, Hannam-Harris AC, et al: Etiologic aspects of cold
                 125. Jacobson LB, Longstreth GF, Edington TS: Clinical and immunologic features of tran-  agglutinin disease: Evidence of cytogenetically defined clones of lymphoid cells and
                  sient cold agglutinin hemolytic anemia. Am J Med 54:514, 1973.  the demonstration that an anti-Pr cold autoantibody is derived from an aberrant B cell
                 126. Murray HW, Masur H, Senterfit LB, Roberts RB: The protean manifestations of Mycop-  clone. Blood 67:1705, 1986.
                  lasma pneumoniae infection in adults. Am J Med 58:229, 1975.    159. Gordon J, Silberstein LE, Moreau L, Nowell PC: Trisomy 3 in cold agglutinin disease.
                 127. Rosenfield RE, Schmidt PJ, Calvo RC, McGinniss MH: Anti-i, a frequent cold aggluti-  Cancer Genet Cytogenet 46:89, 1990.
                  nin in infectious mononucleosis. Vox Sang 10:631, 1965.    160. Michaux L, Dierlamm J, Wlodarska I, et al: Trisomy 3q11-q29 is recurrently observed
                 128. Worlledge SM, Dacie JV: Haemolytic and other anaemias in infectious mononucleosis,     in B-cell non-Hodgkin’s lymphomas associated with cold agglutinin syndrome. Ann
                  in Infectious Mononucleosis, edited by RL Carter, HG Penman, p 82. Blackwell Science,   Hematol 76:201, 1998.
                  Oxford, 1969.                                         161. Harboe M, Lind K: Light chain types of transiently occurring cold haemagglutinins.
                 129. Hossaini AA: Anti-i in infectious mononucleosis. Am J Clin Pathol 53:198, 1970.  Scand J Haematol 3:269, 1966.





          Kaushansky_chapter 54_p0823-0846.indd   842                                                                   9/19/15   12:28 AM
   862   863   864   865   866   867   868   869   870   871   872